TABLE 5.
Logistic regression analysis for 90-day mortality
| 90 D mortality (%. n/N) | Univariable analysis | |||
|---|---|---|---|---|
| 3.1 (22/713) | OR | 95% CI | P | |
| Gender | ||||
| Female | 29 (62/214) | Reference | ||
| Male | 36.5 (182/499) | 1.47 | 0.57–4.53 | 0.451 |
| Age | ||||
| Years | 1.01 | 0.96–1.06 | 0.812 | |
| Obesity (BMI ≥ 30) | ||||
| No | 2.2 (9/413) | Reference | ||
| Yes | 4.3 (13/300) | 2.03 | 0.87–4.99 | 0.107 |
| Hypertension | ||||
| No | 3.9 (6/155) | Reference | ||
| Yes | 2.9 (16/558) | 0.73 | 0.29–2.07 | 0.524 |
| Diabetes | ||||
| No | 1.6 (5/312) | Reference | ||
| Yes | 4.2 (17/401) | 2.71 | 0.99–7.45 | 0.052 |
| Respiratory disease | ||||
| No | 3 (18/601) | Reference | ||
| Yes | 3.6 (4/112) | 1.2 | 0.34–3.29 | 0.746 |
| Ischemic heart disease | ||||
| No | 2.9 (17/579) | Reference | ||
| Yes | 3.7 (5/134) | 1.28 | 0.41–3.31 | 0.632 |
| Dyslipidemia | ||||
| No | 3.3 (10/299) | Reference | ||
| Yes | 2.9 (12/414) | 0.86 | 0.37–2.07 | 0.734 |
| Previous surgery | ||||
| No | 3.3 (20/599) | Reference | ||
| Yes | 1.7 (2/114) | 0.52 | 0.08–1.80 | 0.378 |
| Portal hypertension | ||||
| No | 2.5 (16/640) | Reference | ||
| Yes | 8.2 (6/73) | 3.49 | 1.22–8.81 | 0.012 |
| MELD score | ||||
| < 9 | 1.9 (9/485) | Reference | ||
| ≥ 9 | 5.7 (13/228) | 3.2 | 1.36–7.86 | 0.008 |
| Approach | ||||
| Open | 3.4 (13/380) | Reference | ||
| Minimally invasive | 2.7 (9/333) | 0.78 | 0.32–1.84 | 0.581 |
| Type hepatectomy | ||||
| Minor | 1.7 (8/483) | Reference | ||
| Major | 6.1 (14/230) | 3.84 | 1.62–9.76 | 0.003 |
| Nontumoral parenchyma | ||||
| Normal parenchyma | 3.1 (9/294) | Reference | ||
| NAFL | 0 (0/82) | — | — | — |
| NASH | 3.1 (4/129) | 1.01 | 0.27–3.17 | 0.983 |
| Cirrhosis | 4.3 (9/208) | 1.43 | 0.55–3.73 | 0.455 |
Abbreviations: BMI, body mass index; MELD, Model for End Stage Liver Disease.